Cellosaurus cell line 11060 (CVCL

Cross-references
Cell line name	11060
Synonyms	NMC 11060
Accession	CVCL_C9CM
Resource Identification Initiative	To cite this cell line use: 11060 (RRID:CVCL_C9CM)
Comments	Omics: Deep exome analysis. Omics: Transcriptome analysis by RNAseq. Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
Sequence variations	Gene fusion; HGNC; HGNC:13575; BRD4 + HGNC; HGNC:29919; NUTM1; Name(s)=BRD4-NUTM1, BRD4-NUT (PubMed=20871596).
Disease	NUT carcinoma (NCIt: C45716) NUT midline carcinoma (ORDO: Orphanet_443167)
Species of origin	Homo sapiens (Human) (NCBI Taxonomy: 9606)
Age at sampling	29Y
Category	Cancer cell line
Publications	PubMed=20871596; DOI=10.1038/nature09504; PMCID=PMC3010259 Filippakopoulos P., Qi J., Picaud S., Shen Y., Smith W.B., Fedorov O., Morse E.M., Keates T., Hickman T.T., Felletar I., Philpott M., Munro S., McKeown M.R., Wang Y.-C., Christie A.L., West N.H., Cameron M.J., Schwartz B.E., Heightman T.D., La Thangue N.B., French C.A., Wiest O., Kung A.L.-J., Knapp S., Bradner J.E. Selective inhibition of BET bromodomains. Nature 468:1067-1073(2010) PubMed=29348827; DOI=10.18632/oncotarget.22862; PMCID=PMC5762512 Stirnweiss A., Oommen J., Kotecha R.S., Kees U.R., Beesley A.H. Molecular-genetic profiling and high-throughput in vitro drug screening in NUT midline carcinoma-an aggressive and fatal disease. Oncotarget 8:112313-112329(2017)
Encyclopedic resources	Wikidata; Q123030209
Entry history
Entry creation	05-Oct-2023
Last entry update	19-Dec-2024
Version number	3